https://orcid.org/0000-0001-9642-2977
References
- Chi GC, Kanter MH, Li BH, et al. Trends in acute myocardial infarction by race and ethnicity. J Am Heart Assoc. 2020;2020:e013542.
- Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics – 2022 update: a Report for the American Heart Association. Circulation. 2022;145(8):e153–e639. e153-e639. doi:10.1161/CIR.0000000000001052
- Wang Y, Leifheit EC, Krumholz HM. Trends in 10-year otucomes among Medicare beneficiaries who survived an acute myocardial infarction. JAMA Cardiol. 2022;7(6):613–622. doi:10.1001/jamacardio.2022.0662
- Torio C, Moore B National inpatient hospital costs: the most expensive conditions by payer, 2013. HCUP Statistical Brief #204; 2016. Available from: https://www.hcup-us.ahrq.gov/reports/statbriefs/sb204-Most-Expensive-Hospital-Conditions.jsp. Accessed March 22, 2022.
- Khera R, Hong JC, Saxena A, et al. Burden of catastrophic health expenditures for acute myocardial infarction and stroke among uninsured in the United States. Circulation. 2018;137(4):408–410. doi:10.1161/CIRCULATIONAHA.117.030128
- Cowpar PA, Knight JD, Davidson-Ray L, et al. Acute and 1‐year hospitalization costs for acute myocardial infarction treated with percutaneous coronary intervention: results from the TRANSLATE‐ACS Registry. J Am Heart Assoc. 2019;8:e011322. doi:10.1161/JAHA.118.011322
- Duncan I, Ahmed T, Dove H, Maxwell TL. Medicare cost at end of life. Am J Hosp Palliat Med. 2019;36(8):705–710. doi:10.1177/1049909119836204
- Wammes JJG, van der Wees PJ, Tanke MAC, et al. Systematic review of high-cost patients’ characteristics and healthcare utilisation. BMJ Open. 2018;8:e023113. doi:10.1136/bmjopen-2018-023113
- HCUP National Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). Published by Agency for Healthcare Research and Quality; 2012. Available from: www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed March 10, 2022.
- Urbich M, Globe G, Pantiri K, et al. A systematic review of medical costs associated with heart failure in the USA (2014–2020). Pharmaco Eco. 2020;38:1219–1236. doi:10.1007/s40273-020-00952-0
- Diepen SV, Katz JN, Albert NM, et al. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017;136(16):e232–268. doi:10.1161/CIR.0000000000000525
- Tessier-Sherman B, Galusha D, Taiwo OA, et al. Further validation that claims data are a useful tool for epidemiologic research on hypertension. BMC Public Health. 2013;13(51):33. doi:10.1186/1471-2458-13-51